Takhzyro (lanadelumab)

pCPA File Number: 21175
Negotiation Status:
Active Negotiation
Indication(s):
Hereditary Angioedema
Sponsor/Manufacturer:
Shire Pharma Canada ULC
CADTH Project Number:
SR0618-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable